1. Home
  2. FEAM vs OCUP Comparison

FEAM vs OCUP Comparison

Compare FEAM & OCUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEAM
  • OCUP
  • Stock Information
  • Founded
  • FEAM 2016
  • OCUP 2018
  • Country
  • FEAM United States
  • OCUP United States
  • Employees
  • FEAM N/A
  • OCUP N/A
  • Industry
  • FEAM Major Chemicals
  • OCUP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEAM Industrials
  • OCUP Health Care
  • Exchange
  • FEAM Nasdaq
  • OCUP Nasdaq
  • Market Cap
  • FEAM 44.6M
  • OCUP 53.1M
  • IPO Year
  • FEAM N/A
  • OCUP N/A
  • Fundamental
  • Price
  • FEAM $0.62
  • OCUP $1.22
  • Analyst Decision
  • FEAM Buy
  • OCUP Strong Buy
  • Analyst Count
  • FEAM 4
  • OCUP 3
  • Target Price
  • FEAM $4.19
  • OCUP $18.67
  • AVG Volume (30 Days)
  • FEAM 160.6K
  • OCUP 96.2K
  • Earning Date
  • FEAM 11-07-2024
  • OCUP 11-11-2024
  • Dividend Yield
  • FEAM N/A
  • OCUP N/A
  • EPS Growth
  • FEAM N/A
  • OCUP N/A
  • EPS
  • FEAM N/A
  • OCUP N/A
  • Revenue
  • FEAM N/A
  • OCUP $16,449,000.00
  • Revenue This Year
  • FEAM N/A
  • OCUP N/A
  • Revenue Next Year
  • FEAM $1,117.19
  • OCUP $258.69
  • P/E Ratio
  • FEAM N/A
  • OCUP N/A
  • Revenue Growth
  • FEAM N/A
  • OCUP N/A
  • 52 Week Low
  • FEAM $0.40
  • OCUP $1.15
  • 52 Week High
  • FEAM $3.15
  • OCUP $3.40
  • Technical
  • Relative Strength Index (RSI)
  • FEAM 50.42
  • OCUP 40.68
  • Support Level
  • FEAM $0.60
  • OCUP $1.24
  • Resistance Level
  • FEAM $0.66
  • OCUP $1.39
  • Average True Range (ATR)
  • FEAM 0.09
  • OCUP 0.07
  • MACD
  • FEAM 0.02
  • OCUP -0.00
  • Stochastic Oscillator
  • FEAM 54.59
  • OCUP 4.76

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About OCUP Ocuphire Pharma Inc.

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

Share on Social Networks: